Quote On Cadila Healthcare 3QFY21 By Yash Gupta, Angel Broking Â
Cadila reported numbers inline expectation, Cadila Healthcare limited total revenue from operations for Q3FY21 stood at ₹3,754 crores up by 6% YoY from ₹3,541crores in Q3FY20. EBITDA for Q3FY21 stood at ₹807 crores up by 16% as compared to ₹695 crores in Q3FY20. Profit after tax for the quarter up by 41% at 527₹ crores in Q3FY21 as compared to ₹373 crores in Q3FY20.
Company’s domestic business posted strong growth during the quarter grew by 20% on a y-o-y basis and registered revenues of ₹1,643 crore while USA business growth slightly lower than the expected, USA formulation business registered revenue of ₹1603 crores. We have a Positive outlook towards Cadila healthcare limited.
Above views are of the author and not of the website kindly read disclaimer
